T-type Ca2+ channel blockers suppress the growth of human cancer cells
- 1 July 2008
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (14), 3899-3901
- https://doi.org/10.1016/j.bmcl.2008.06.034
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- T-type Ca2+ channel expression in human esophageal carcinomas: A functional role in proliferationCell Calcium, 2008
- Discovery of potent T-type calcium channel blockerBioorganic & Medicinal Chemistry Letters, 2007
- The pharmacology and regulation of T type calcium channels: New opportunities for unique therapeutics for cancerCell Calcium, 2006
- T-type calcium channels in differentiation and proliferationCell Calcium, 2006
- Effect of miconazole on intracellular Ca2+ levels and proliferation in human osteosarcoma cellsLife Sciences, 2005
- The biochemical activation of T-type Ca2+ channels in HEK293 cells stably expressing α1G and Kir2.1 subunitsBiochemical and Biophysical Research Communications, 2004
- Variation of T-type calcium channel protein expression affects cell division of cultured tumor cellsCell Calcium, 2004
- Inhibition by mibefradil, a novel calcium channel antagonist, of Ca2+‐ and volume‐activated Cl− channels in macrovascular endothelial cellsBritish Journal of Pharmacology, 1997
- Mibefradil Prevents Neointima Formation After Vascular Injury in RatsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990